IL153449A0 - Reusable extracorporeal columns loaded with liganddibiotin conjugates - Google Patents

Reusable extracorporeal columns loaded with liganddibiotin conjugates

Info

Publication number
IL153449A0
IL153449A0 IL15344901A IL15344901A IL153449A0 IL 153449 A0 IL153449 A0 IL 153449A0 IL 15344901 A IL15344901 A IL 15344901A IL 15344901 A IL15344901 A IL 15344901A IL 153449 A0 IL153449 A0 IL 153449A0
Authority
IL
Israel
Prior art keywords
liganddibiotin
conjugates
extracorporeal
columns loaded
reusable
Prior art date
Application number
IL15344901A
Other languages
English (en)
Original Assignee
Department Of Radiation Oncolo
Mitra Medical Technology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Department Of Radiation Oncolo, Mitra Medical Technology Ab filed Critical Department Of Radiation Oncolo
Publication of IL153449A0 publication Critical patent/IL153449A0/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL15344901A 2000-06-16 2001-06-18 Reusable extracorporeal columns loaded with liganddibiotin conjugates IL153449A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (1)

Publication Number Publication Date
IL153449A0 true IL153449A0 (en) 2003-07-06

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15344901A IL153449A0 (en) 2000-06-16 2001-06-18 Reusable extracorporeal columns loaded with liganddibiotin conjugates

Country Status (14)

Country Link
EP (1) EP1289563B1 (ja)
JP (1) JP2004503299A (ja)
CN (1) CN1457260A (ja)
AT (1) ATE469661T1 (ja)
AU (2) AU7476101A (ja)
BR (1) BR0111726A (ja)
CA (1) CA2412495C (ja)
DE (1) DE60142286D1 (ja)
HU (1) HUP0401953A3 (ja)
IL (1) IL153449A0 (ja)
MX (1) MXPA02012438A (ja)
NO (1) NO20025931L (ja)
PL (1) PL359328A1 (ja)
WO (1) WO2001095857A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52060B (en) * 2006-01-25 2012-04-30 Sanofi CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES
BRPI0820156B8 (pt) * 2007-11-12 2021-05-25 Chreto Aps processo para purificação de uma biomolécula alvo
CN110078787A (zh) * 2011-05-27 2019-08-02 Ambrx 公司 含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
CA2837167A1 (en) * 2011-05-27 2012-12-06 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
EP3842440A3 (en) * 2014-02-18 2021-07-07 Savid Therapeutics Inc. Modified biotin, streptavidin mutant, and usage of them
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
CN110088129A (zh) * 2016-12-27 2019-08-02 豪夫迈·罗氏有限公司 新的生物素特异性单克隆抗体及其用途
EP3562845A2 (en) 2016-12-27 2019-11-06 H. Hoffnabb-La Roche Ag Novel biotin-specific monoclonal antibody and use thereof
US11442066B2 (en) 2017-02-17 2022-09-13 Mitsui Chemicals, Inc Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
AU2052497A (en) * 1996-02-08 1997-08-28 Board Of Regents Of The University Of Washington, The Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
WO2001095857A3 (en) 2002-03-28
AU2001274761B2 (en) 2005-06-16
MXPA02012438A (es) 2004-09-06
HUP0401953A3 (en) 2005-06-28
AU7476101A (en) 2001-12-24
ATE469661T1 (de) 2010-06-15
EP1289563B1 (en) 2010-06-02
NO20025931L (no) 2003-02-14
CA2412495C (en) 2011-02-01
WO2001095857A2 (en) 2001-12-20
NO20025931D0 (no) 2002-12-11
HUP0401953A2 (hu) 2004-12-28
JP2004503299A (ja) 2004-02-05
PL359328A1 (en) 2004-08-23
DE60142286D1 (de) 2010-07-15
CA2412495A1 (en) 2001-12-20
EP1289563A2 (en) 2003-03-12
BR0111726A (pt) 2003-05-27
CN1457260A (zh) 2003-11-19

Similar Documents

Publication Publication Date Title
WO2001036977A3 (en) Identification of disease markers involving mass-based-separation
AU2001242309A1 (en) A disposable lancet combined with a reagent carrying strip and a system for extracting and analysing blood in the body utilizing such a disposable lancet
AU2002359620A1 (en) Consolidated body fluid testing device and method
ES2167434T3 (es) Sistema de recogida de sangre.
WO2005086874A3 (en) Energy assisted medical devices, systems and methods
EP2363477A3 (en) Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
WO2002082975A3 (en) Biological tissue strip and system and method to seal tissue
WO2003020335A3 (en) Dual stage microvalve and method of use
AU2002220577A1 (en) Circulatory device for separating substances in bodily fluids, especially blood,and the use of said device
AU8580501A (en) Method for carrying out a saliva analysis
IL153449A0 (en) Reusable extracorporeal columns loaded with liganddibiotin conjugates
BRPI0417417A (pt) sistema de coleta de amostra de inibidor de fosfatase
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
SE0002287D0 (sv) Biotinderivat
WO2001085949A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
WO2006130799A3 (en) Bioconjugation reactions for acylating polyethlene glycol reagents
WO2001048476A3 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten
AU2001256447A1 (en) Sampling device with tubes having different cross-section
WO2003061622A3 (de) Verfahren und vorrichtumg tum einbringen von lebenden zellen in eine biologische körperflüssigkeit
WO2001078785A3 (de) Wirkstoff-konjugate mit intrazellulär wirksamen liganden
WO2002053016A3 (en) Compounds and methods for the diagnosis and treatment of babesia infection
Hoogewijs et al. Development of a standardized analysis strategy for basic drugs using ion-pair extraction and high-performance liquid chromatography. VIII. Method construction for the determination of mebeverine in tablets and biological fluids
ZA200202506B (en) Method and device for the rapid clinical diagnosis of hepatitis B virus (HBV) infection in biological samples.
UA38285A (uk) Спосіб визначення мікрокількостей германію в тканинах тварин
UA40213A (uk) Спосіб індивідуальної оцінки ефективності сорбенту

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees